Jazz Pharmaceuticals (JAZZ) jumped 4.89% over the past two days after announcing better-than-expected earnings. Quarterly revenues increased 67.7% year over year to $208.3 million. Second-quarter 2013 adjusted earnings of $1 per share were well above the year-ago earnings of 81 cents per share.
With your September 2013 $70.000 calls (JAZZ130921C00070000) now up 101.64%, sell all of your remaining options to lock in these triple-digit percentage gains.
With Jazz Pharmaceuticals (JAZZ) up 40.99% since my initial recommendation on May 13, raise your stop in the stock to $78.30 to lock in at least a 35% gain in the stock.
There is a famous saying that has been floating around the internet regarding the “Five…
Today is May 1, a day that’s also known as “May Day” in many countries…
Ten reasons to day-trade with mentors in a virtual room highlight why now is a…
Last year’s fourth-quarter downtrend for inflation looks to have bottomed out at just under the…
The intrinsic and extrinsic value of an option make up the total value of the…
Picture this: You've diligently saved for retirement your whole career, dutifully contributing to your 401(k),…